Date of Presentation

5-2-2024 12:00 AM

College

Rowan-Virtua School of Osteopathic Medicine

Poster Abstract

This study examines the relationship between C-reactive protein (CRP) levels and cardiovascular disease (CVD) risk in 293 patients with Autism Spectrum Disorder (ASD) from the Rowan-Virtua Regional Integrated Special Needs Center (RISN Center). Baseline CRP values were gathered from EMR and evaluated for CVD risk. ASD patients have increased prevalence of CVD risk factors, and the literature demonstrates a strong relationship between CRP and CVD risk in this population. Patients were stratified by severity of ASD to investigate potential differences. Severe limitations in EMR data and overall sample size limited the generalizability and significance of this study. Larger scale studies with ample serum CRP values are needed to adequately assess CVD risk in the RISN Center’s ASD patient population. Regular monitoring and evaluation of CRP levels in ASD patients could lead to better management of cardiovascular health in patients with ASD.

Keywords

Autism Spectrum Disorder, C-Reactive Protein, Cardiovascular Disease, Neurodivergent

Disciplines

Cardiovascular Diseases | Medicine and Health Sciences | Nervous System Diseases | Pathological Conditions, Signs and Symptoms | Translational Medical Research

Document Type

Poster

DOI

10.31986/issn.2689-0690_rdw.stratford_research_day.13_2024

Share

COinS
 
May 2nd, 12:00 AM

Evaluating C-Reactive Protein Associated Risk of Cardiovascular Disease in Patients with Autism Spectrum Disorder

This study examines the relationship between C-reactive protein (CRP) levels and cardiovascular disease (CVD) risk in 293 patients with Autism Spectrum Disorder (ASD) from the Rowan-Virtua Regional Integrated Special Needs Center (RISN Center). Baseline CRP values were gathered from EMR and evaluated for CVD risk. ASD patients have increased prevalence of CVD risk factors, and the literature demonstrates a strong relationship between CRP and CVD risk in this population. Patients were stratified by severity of ASD to investigate potential differences. Severe limitations in EMR data and overall sample size limited the generalizability and significance of this study. Larger scale studies with ample serum CRP values are needed to adequately assess CVD risk in the RISN Center’s ASD patient population. Regular monitoring and evaluation of CRP levels in ASD patients could lead to better management of cardiovascular health in patients with ASD.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.